Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.3 USD | +0.96% | +5.62% | -29.27% |
Business Summary
Number of employees: 48
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnological Applications
100.0
%
| 26 | 100.0 % | 43 | 100.0 % | +65.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States, Germany and Australia
100.0
%
| 26 | 100.0 % | 43 | 100.0 % | +65.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Yoder
CEO | Chief Executive Officer | 48 | 09-12-31 |
Thomas Bures
DFI | Director of Finance/CFO | 49 | 17-11-30 |
Kayti Aviano
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 19-08-29 |
Shane Olwill
PRN | Corporate Officer/Principal | 48 | 11-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 16-09-19 | |
James Geraghty
CHM | Chairman | 69 | 17-05-21 |
Michael Richman
BRD | Director/Board Member | 63 | 14-12-16 |
Matthew Sherman
BRD | Director/Board Member | 68 | 18-10-24 |
Peter Kiener
BRD | Director/Board Member | 72 | 18-09-09 |
Stephen Yoder
CEO | Chief Executive Officer | 48 | 09-12-31 |
Maya Said
BRD | Director/Board Member | 47 | 19-07-30 |
Ann J. Barbier
BRD | Director/Board Member | 59 | 18-04-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,506 | 0 | 0 | 93.03 % |
Stock B | 0 | 4,026 | 0 | 0 | |
Stock C | 1 | 1,320,240 | 1,228,236 ( 93.03 %) | 0 | |
Stock D | 0 | 85 | 0 | 0 |
Company contact information
Pieris Pharmaceuticals, Inc.
225 Franklin Street 9th floor
02109, Boston
+857 246 8998
http://www.pieris.comSector
1st Jan change | Capi. | |
---|---|---|
-29.27% | 13.47M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- PIRS Stock
- Company Pieris Pharmaceuticals, Inc.